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Abstract 
Background and objectives: Analgesia after caesarean section is important because 
postpartum women with pain have difficulty in mobility, which undermines breastfeeding. 
Intrathecal morphine provides adequate and prolonged analgesia after cesarean. The aim 
of this study was to compare the quality of analgesia provided by two doses of intrathecal 
morphine and its side effects in patients undergoing cesarean section.
Method: The study included 123 pregnant women with gestational age over 38 weeks and 
scheduled for cesarean section. The women were randomly allocated into two groups to 
receive either 50 or 100 μg of intrathecal morphine (Group 50/Group 100). All patients 
were intrathecally anesthetized with 12 mg of 0.5% hyperbaric bupivacaine. Patients were 
assessed between the 9th and 11th hour and the 22nd and 24th hour after blockade for quality 
of analgesia, analgesic consumption, side effects, and main cause of discomfort in the first 
24 hours after surgery.
Results: There was similarity between groups regarding anthropometric data and obstetric 
history. There was no statistical difference in pain intensity between groups. In both 
groups, pain was more intense in the first 12 hours after anesthesia (p < 0.001). Tramadol 
hydrochloride consumption and time to first dose were similar in both groups. Pruritus was the 
most common side effect, with statistically higher incidence in Group 100 (p = 0.026). 
Conclusions: Intrathecal morphine 50 μg provides the same quality of analgesia as 100 μg, 
with a lower incidence of side effects.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Postoperative analgesia enables a faster rehabilitation, 
improves the patient’s level of satisfaction, and reduces 
hospital stay.1,2 In obstetrics, postoperative analgesia is 
important because postpartum women with pain have 
difficulty in walking and may adopt antalgic positions that 
hinder the initiation of breastfeeding.3 Moreover, endocrine 
changes and stress resulting from pain may interfere with 
lactation.4
Intrathecally administered morphine is the most 
widely used drug for analgesia after caesarean section, 
as it promotes adequate and long-lasting postoperative 
analgesia even at low doses.5,6 However, it may cause side 
effects such as nausea, vomiting, pruritus, sedation, and 
respiratory depression.
The quality of analgesia and incidence of side effects 
may vary according to the intrathecal dose of morphine 
used.5 The optimal dose capable of providing better 
analgesia with the lowest incidence of side effects has not 
yet been defined.
The main objective of this study was to compare 
analgesia at rest and in motion, provided by two doses 
of intrathecal morphine in patients undergoing cesarean 
section. Moreover, the need for supplementary analgesics, 
incidence of side effects, main cause of discomfort within 
the 24 hours of the study, and level of patient satisfaction 
regarding analgesia were also compared.
Patients and method
After approval by the Ethics Committee of the Hospital de 
Clínicas/UFPR and Hospital Santa Cruz, 130 pregnant women, 
ASA I-III, were invited to participate in this study. Inclusion 
criteria were: single-fetus pregnancy, more than 38 weeks of 
gestational age and scheduled for elective cesarean section. 
Exclusion criteria were: body mass index greater than 40 
kg•m2, a history of more than three prior cesareans, allergy to 
any of the study medications, psychiatric or cardiopulmonary 
disease or decompensated diabetes mellitus, and chronic use 
of analgesics. Patients received the informed consent with 
information on this study, which was signed after reading and 
clarification of any doubts.
The study was double-blind and, using a on-line 
randomization program (www.randon.org), the study 
participants were randomly allocated into two groups: 
Group 50 and Group 100.
Upon arrival at the operating room, peripheral venous 
access was obtained using an 18G catheter and Ringer’s 
lactate solution (250 mL) was infused with cefazolin (1 
g) for antibiotic prophylaxis. After monitoring with non-
invasive blood pressure, pulse oximetry, and cardioscopy, 
patients were placed in a sitting position to receive 
anesthesia. Spinal puncture was performed with a 27G 
pencil point needle under topical anesthesia, with 2% 
lidocaine without vasoconstrictor, through L3-L4 or L4-L5 
intervertebral spaces. For intrathecal anesthesia, 0.5% 
hyperbaric bupivacaine (12 mg) was administered. Patients 
in Group 50 received 50 μg of morphine associated with 
bupivacaine, whereas Group 100 received 100 μg associated 
with bupivacaine. Morphine was administered in proper 
syringe, after the local anesthetic.
After anesthesia, patients were kept supine, with the 
uterus manually shifted to the left to avoid compression 
of inferior vena cava, and received oxygen (2-3 L•min–1) 
via nasal catheter. For hypotension correction, fluid 
resuscitation with Ringer’s lactate solution was used, 
associated with phenylephrine or metaraminol, at the 
discretion of the anesthesiologist responsible for the case. 
The objective was to maintain systolic blood pressure 
greater than 100 mmHg. In cases of bradycardia, with heart 
rate less than 45 bpm, atropine (0.5 mg) was used. After 
birth, oxytocin (05-15 U/I) diluted in Ringer’s lactate was 
administered to stimulate uterine contraction.
At the end of surgery, patients were taken to the post-
anesthesia care unit (PACU) and received intravenous 
ketorolac tromethamine (30 mg), dipyrone (2 g), and 
bromopride (10 mg). Cases of muscle tremor were treated 
with pethidine hydrochloride (30 mg). Patients were 
discharged from PACU after completing 9 points in the 
modified Aldrete-Kroulik scale.7 Postoperative analgesic 
and antiemetic prescriptions were standardized. Patients 
received ketoprofen (100 mg every 12 hours), dipyrone 
(1 g every six hours), and bromopride (10 mg every six 
hours). Tramadol hydrochloride (50 mg) was prescribed 
as rescue analgesic. For nausea and vomiting episodes, 
ondansetron (4 mg) was prescribed and for cases of itching, 
diphenhydramine hydrochloride (25 mg).
Postoperative evaluations were made between the 
9th and 11th hour and the 24th and 22nd hour after 
anesthesia by a nurse who was blinded to which group 
the patient belonged. A questionnaire was used to be 
filled out by patient and evaluator. Evaluated data were 
postoperative pain intensity, worst pain experienced at 
each period of time (first period: between anesthesia and 
first assessment; second period: between first and second 
evaluation), supplementary analgesic consumption, time 
interval between anesthesia and first dose of medication, 
side effects, main cause of discomfort at 24 hours, and 
satisfaction regarding analgesia.
Postoperative pain intensity was assessed with patients 
at rest and in motion. To standardize the assessment in 
motion and facilitate comparison, it has been determined 
that all patients should cough three times. A 10 cm long 
visual analogue scale (VAS), not numbered, was used. At 
this scale, the left end represents no pain and the right 
end represents the worst possible pain. The patient rated 
the pain she was feeling, and located it at one point of the 
scale. The distance between the left end and the point 
indicated by the patient corresponded to the intensity 
of pain. Pain intensity was considered mild (up to 3), 
moderate (4 to 6), and severe8 (7 to 10).
Pruritus, nausea, vomiting, voiding difficulty, dizziness, 
sedation, and respiratory depression were assessed. 
Patients were also asked if it was the pain or any of the side 
effects that caused more discomfort within the 24 hours 
of the study. Voiding difficulty was considered in patients 
who presented with no diuresis until the first evaluation. 
Patients’ satisfaction regarding analgesia was assessed as 
very good, good, fair, and poor, which corresponded to 
rates 9-10, 7-8, 4-5-6, and 1-2-3, respectively.
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Sample size calculation was based on studies by Mikuni 
et al.9 and Paech et al.,10 considering a significance level of 
5% and power of 90%.
The study results are expressed as mean, median, 
minimum-maximum values, and standard deviations 
(quantitative variables) or as frequencies and percentages 
(qualitative variables). To compare both groups regarding 
quantitative variables, we considered Student t-test for 
independent samples or nonparametric Mann-Whitney 
test, when appropriate. Comparison between the two 
evaluations for quantitative variables was performed using 
the nonparametric Wilcoxon’s test. For association between 
qualitative variables, we considered the chi-square or 
Fisher’s exact test. Pearson’s correlation coefficient was 
considered to assess the association between quantitative 
variables. To estimate parameters of interest, confidence 
intervals of 95% were constructed. For all tests, p values 
< 0.05 were considered statistically significant. Data were 
analyzed with the Statistica software v.8.0.
Results
Of the 130 patients participating in this study, five from 
Group 50 and two from Group 100 refused to respond the 
second evaluation due to visit’s time and were excluded 
from the analysis.
The groups were homogeneous regarding anthropometric 
data (Table 1). Regarding the number of pregnancies and 
previous cesareans, the groups were also similar.
Both groups had similar pain intensity at rest and when 
coughing in both assessments (Table 2). 
There was no statistical difference between groups 
regarding worst pain at the first and second periods (Table 
2). Comparison between times showed that pain intensity 
was significantly higher in both groups at the first period 
(Table 3).
There was no statistical difference in moderate/severe 
pain probability between Group 50 and Group 100, but 
the probability of moderate/severe pain was statistically 
higher in the first 12 hours after surgery in both groups 
(Tables 4 and 5).
In Group 50, 15% of patients requested tramadol 
hydrochloride and in Group 100, 8% of patients requested 
analgesia (p = 0.263). The mean interval between anesthesia 
and the first dose of medication was 496 minutes in Group 
50 and 452 minutes in Group 100 (p = 0.740).
In Group 50, the interval between anesthesia and the 
first urination was 650 ± 128 minutes and in Group 100 
it was 694 ± 155 minutes (p = 0.094). The probability of 
voiding difficulty was also higher in Group 100, but without 
statistical difference (p = 0.194).
Among side effects, only itching was significantly higher 
in Group 100 compared to Group 50 (Fig. 1). Side effects 
were more frequent at first period in both groups (Table 
6). There were no cases with sedation and/or respiratory 
depression.
When asked what bothered them most during the 24 
hours after cesarean section, 70% of patients in Group 50 
elected pain as the main cause of discomfort, followed by 
voiding difficulty (15%) and pruritus (12%). In Group 100, 
the main cause of discomfort was also pain (38%), followed 
by pruritus (32%), and voiding difficulty (16%) (Table 7). 
Regarding satisfaction, 82% of patients in Group 50 
and 83% in Group 100 classified analgesia as good or very 
good at first period (p = 0.785). At the second period, 95% 
of patients in Group 50 and 87% in Group 100 classified 
analgesia as good or very good (p = 0.245).
Discussion
Pain assessment is complex because it is influenced by 
emotional, ethnic, cultural, and cognitive factors. To 
standardize and make this assessment more objective, 
scales for pain assessment were created. The most used 
are the VAS and the verbal numeric scale (VNS). They 
are easy to apply and when compared to the verbal scale 
(VS), they are more accurate and able to detect subtle 
differences.8 For these reasons, we opted for using the 
VAS as a pain assessment method in this study. The time 
interval between anesthesia and the first dose of analgesic 
or total analgesic consumption are other ways to measure 
Table 1 Anthropometric data of patients.
Variable Group 50 Group 100 pa 
 n = 60 n = 63 
Ageb (years) 28.1 ± 5.2 29.4 ± 4.8 0.132
Current weighb (kg) 77.6 ± 11.8 79.9 ± 10.0 0.250
Previous weightb (kg) 64.7 ± 10.7 66.8 ± 10.9 0.280
Heightb (m) 1.6 ± 0.1 1.6 ± 0.1 0.728
BMIb (kg•m2)c 28.7 ± 3.8 29.8 ± 3.9 0.127
BMI, body mass index.
Group 50, received 50 μg morphine; Group 100, received 100 μg morphine.
a Student’s t-test for independent samples, p < 0.05.
b Values expressed as mean ± SD.
c Body mass index, using current weight.
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the effectiveness of analgesia.5
The use of 50 and 100 μg of intrathecal morphine 
did not show statistically significant difference in 
pain evaluation between both groups of patients who 
underwent caesarean section. This result showed that 
there is no direct relationship between the dose of 
intrathecal morphine and quality of analgesia, which 
are consistent with the results of other authors. Cardoso 
compared 25, 50, and 100 μg of intrathecal morphine 
and reported analgesia statistically better in the group 
receiving 100 μg; however, analgesia was satisfactory in 
all groups without clinical difference between them.11 No 
patient required systemic opioid to supplement analgesia. 
Ganem et al.12 used 50 and 100 μg of intrathecal morphin 
and also reported similar analgesia between groups. In 
the study by Girgin et al.,13 100, 200, 300 and 400 μg of 
intrathecal morphine were compared with a control group 
not receiving morphine. The study showed no statistical 
Table 3 Pain comparison regarding periods for each group.
Group Pain assessment  Median Min Max pa
M50 (n = 60) Pain at rest 1b  0.70 0 8.70 
 Pain at rest 2c 0.60 0 4.90 0.183
 Pain when coughing 1b  3.75 0.10 8.70 
 Pain when coughing 2c 2.75 0.10 8.40 < 0.001
 Worst pain period 1d 5.10 0.20 10 
 Worst pain period 2e 4.60 0.20 9.70 0.001
M100 (n = 63) Pain at rest 1b  0.60 0 6.30 
 Pain at rest 2c  0.40 0 6.10 0.358
 Pain when coughing 1b  3.40 0.20 9.20 
 Pain when coughing 2e 2.80 0.20 9.30 < 0.001
 Worst pain period 1d  4.70 0.40 9.90 
 Worst pain period 2e 3.20 0.20 9.30 < 0.001
Group 50, received 50 μg morphine; Group 100, received 100 μg morphine.
a Nonparametric Wilcoxon’s test, p < 0.05.
b First evaluation, i.e., period between the 9th and 11th hour after anesthesia.
c Second evaluation, i.e., period between the 22nd and 24th hour after anesthesia.
d Period between anesthesia and first evaluation.
e Period between the first and second evaluation.
Table 2 Pain comparison bet
Pain assessmenta Group n Median Min Max pb
Pain at rest 1c M50 60 0.70 0 8.70 
 M100 63 0.60 0 6.30 0.974
Pain when coughing 1c  M50 60 3.75 0.10 8.70 
 M100 63 3.40 0.20 9.20 0.757
Worst pain period 1d M50 60 5.10 0.20 10 
 M100 63 4.70 0.40 9.90 0.540
Pain at rest 2e M50 60 0.60 0 4.90 
 M100 63 0.40 0 6.10 0.862
Pain when coughing 2e M50 60 2.75 0.10 8.40 
 M100 63 2.80 0.20 9.30 0.387
Worst pain period 2f M50 60 4.60 0.20 9.70 
 M100 63 3.20 0.20 9.30 0.192
Group 50, received 50 μg morphine; Group 100, received 100 μg morphine.
a Visual analog scale.
b Nonparametric Mann-Whitney test, p < 0.05.
c First evaluation, i.e., period between the 9th and 11th hour after anesthesia.
d Period between anesthesia and first evaluation.
e Second evaluation, i.e., between the 24th and 22nd hour after anesthesia.
f Period between the first and second evaluation.
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difference in the quality of analgesia and consumption of 
supplemental analgesic between groups receiving opioids. 
Palmer et al.6 evaluated the use of intravenous morphine 
after using 0, 25, 50, 75, 100, 200, 300, 400, and 500 
Table 5 Difference in probability of moderate/severe paina between periods in each group.
  Assessment 1b Assessment 2c p
Group 50, n = 60, moderate/severe pain   
 Rest 12 8 0.687
 Cough 62 47 0.049
 Worst pain period  77 62 0.035
Group 100, n = 63, moderate/severe pain   
 Rest 18 11 0.344
 Cough 59 44 0.035
 Worst pain period 73 54 0.002
Values are expressed as percentage.
a Moderate/severe pain > 3 assessed with visual analogue scale.
b First evaluation, i.e., period between the 9th and 11th hour after anesthesia.
c Second evaluation, i.e., period between the 24th and 22nd hour after anesthesia.
Table 4 Difference in probability of moderate/severe paina between groups at each time period.
 Group 50 Group 100 p 
 n = 60 n = 63 
Assessment 1,b moderate/severe pain   
 Rest 12 18 0.448
 Cough 62 59 0.854
 Worst pain period 1c 77 73 0.682
Assessment 2,d moderate/severe pain   
 Rest 8 11 0.763
 Cough 47 44 0.857
 Worst pain period 2e 62 54 1
Values are expressed as percentage.
a Moderate/severe pain > 3 assessed with visual analogue scale.
b First evaluation, i.e., period between the 9th and 11th hour after anesthesia.
c Period between anesthesia and first evaluation.
d Second evaluation, i.e., period between the 24th and 22nd hour after anesthesia.
e Period between the first and second evaluation.
18.33 23.81
70
58.33
87.3
69.84
15 19.05
Group 50 Group 100
Pruritus (p = 0.026) Voiding difficulty (p = 0.194) Dizziness (p = 0.635)Nausea/Vomiting (p = 0.512)
Figure 1 Incidence of side effects in at least one period in each group. Values are expressed as percentages.
μg of intrathecal morphine for analgesia after cesarean 
section. There was no statistical difference in morphine 
consumption in groups receiving intravenous doses greater 
than 25 μg of intrathecal morphine. 
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The first 12 hours after cesarean section corresponded 
to the period of worst pain intensity. In both groups, pain 
when coughing and the worst pain of the period were 
statistically greater in the first assessment. The incidence 
of moderate/severe pain (greater than 3 on VAS) was also 
greater at the first 12 hours. In Group 50, 77% of patients 
reported moderate/severe pain in the first period and 62% 
of patients in the second (p = 0.035). In Group 100, 73% 
of patients experienced moderate/severe pain in the first 
period and 54% of patients in the second (p = 0.002).
In this study, the worst pain felt in each period had 
mean and median < 3 in both groups. This result is opposed 
to that of Cardoso et al.11 who compared similar doses of 
intrathecal morphine using VAS and reported that the mean 
pain during 24 hours was > 1 in all groups. Possibly, the 
difference in pain intensity between studies was because 
Cardoso evaluated the patients from the first hour after 
blockade, at one-hour interval.11 Pain intensity in the first 
hours after anesthesia is less intense due to the residual 
effect of local anesthetic, which certainly reduced the 
mean pain for 24 hours. In the present study, it was decided 
to evaluate patients after anesthesia regression, on two 
times, between the 9th and 11th hour and the 22nd and 24th 
hour after anesthesia.
In both groups, tramadol hydrochloride consumption was 
surprisingly low, considering the incidence of moderate/
severe pain. Only 15% of patients in Group 50 requested 
analgesia, while in Group 100, 8% of patients requested 
analgesia (p = 0.263). This fact illustrates the ineffectiveness 
of prescriptions using dosing schedule only when necessary. 
Possibly, analgesic consumption would be greater in both 
groups if a system of patient-controlled analgesia (PCA) had 
been used, as well as lower pain intensity. In 2002, Dollin 
et al.14 reported better pain control and a lower incidence 
of moderate/severe pain in patients using PCA compared to 
patients receiving analgesics only when requested.
Time interval between anesthesia and the first analgesic 
dose was not statistically different between groups. Sarvela 
et al.15 compared 100 and 200 μg of intrathecal morphine 
with 3 mg of epidural morphine for cesarean section 
analgesia and also found statistically similar time interval 
between anesthesia and the first dose of analgesic. In the 
study by Girgin study,13 time interval to first analgesic dose 
was lower in control group, but there was no statistical 
difference between groups receiving morphine. These 
results differ from those presented by Abboud et al.16 
and Uchiyama et al.17 who reported duration of analgesia 
directly proportional to the dose of morphine. 
Pruritus is the most common side effect after the use of 
intrathecal morphine and has a variable incidence.5,11,15,18 
In obstetric patients, it may be more frequent due to 
the interaction with estrogen receptors Mu19 (μ). In 
the presentstudy, it was the most frequent side effect, 
experienced by 70% of patients in Group 50 and 87% in 
Group 100 (p = 0.026). This dose-dependent effect is 
consistent with the systematic review by Dahl, reporting 
Table 7 Main factors of discomfort over 24 hours in each study group.a
Group 50 Group 100
n = 60 n = 63
1st Pain 70 1st Pain 38
2nd Voiding difficulty 15 2nd Pruritus 32
3rd Pruritus 12 3rd Voiding difficulty 16
4th Dizziness 2 4th Nausea/vomiting 11
5th Nausea/vomiting 2 5th Dizziness 3
a Values are expressed as percentage of patients reporting each complaint.
Table 6 Relationship between side effects and periods.
 Group 50  Group 100
 n = 60  n = 63
 Period 1a Period 2b Period 1a Period 2b
Pruritus 67 17 83 30
Voiding difficulty 58 0 70 0
Nausea/vomiting 18 0 24 2
Dizziness 15 0 19 0
Values are expressed as percentage.
a Period between anesthesia and first evaluation. 
b Period between the first and second evaluation.
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that the incidence of pruritus varies directly according 
morphine dose.5 In the study by Cardoso et al.,11 the 
incidence of pruritus in groups receiving 25, 50, and 
100 μg of intrathecal morphine was 33%, 33%, and 58%, 
respectively (p < 0.05). The likely cause for the difference 
in the incidence of pruritus is that Cardoso considered 
only cases requiring treatment, while this study included 
all patients who reported pruritus. The study by Sarvela 
reported 77% incidence of pruritus.15
Urinary retention was the second most frequent side 
effect. The incidence in Group 50 was 58%, with a mean time 
interval until the first urination of 650 minutes, and 70% in 
Group 100, with a mean interval until the first urination 
of 693 minutes. Despite the numerical difference between 
groups, it was not statically significant and all patients 
had voiding activity normalized in the second evaluation. 
For urinary retention diagnosis, some authors use the 
residual volume of urine in the bladder after urination or 
consider the need for catheterization or frustrated attempt 
of spontaneous voiding.20,21 These conceptual differences 
associated with the use of urinary catheterization during 
cesarean section in some services make it difficult to 
determine the incidence of urinary retention.22 In this 
study, we chose to consider as having urinary retention all 
patients who had not experienced diuresis until the first 
evaluation. This difference may explain the high incidence 
of this side effect in the study. Kuipers et al.22 assessed the 
effect of intrathecally administered opioids on urinary tract 
and reported a reduction in the bladder detrusor muscle 
contractility associated with a reduction in the urgency 
sensation, resulting in urinary retention. The intensity and 
duration of this effect was dose-dependent.22
The incidence of nausea/vomiting was not statistically 
different between groups. This result is consistent with 
that of other authors. Cardoso et al.11 found only a 
trend towards a higher incidence of nausea and vomiting 
with increased dose of intrathecal morphine (p > 0.05). 
Ganem et al.12 reported incidence of nausea and vomiting 
statistically similar between patients who received 50 or 
100 μg of intrathecal morphine. Palmer et al.6 and Girgin 
et al.13 compared increasing doses of intrathecal morphine 
and reported that the incidence and severity of nausea and 
vomiting did not vary with the dose used. 
There was no case of sedation or respiratory depression, 
which does not mean that these side effects will not occur. 
Possibly, the small number of patients involved in the 
study justifies this result. Sedation is considered a warning 
sign, as it may precede respiratory depression – the most 
feared side effect of intrathecal morphine. The incidence 
of respiratory depression is less than 1% and may occur 
up to 24 hours after administration. In obstetric patients, 
the incidence seems to be lower due to the respiratory 
stimulation caused by high levels of progesterone.19 In a 
review by Dahl, the incidence of respiratory depression 
following caesarean section was 0.2%.5
Regardless of morphine dosage, the incidence of 
moderate/severe pain was higher than 70% in the first 
period and higher than 50% in the second period. Despite 
the high incidence of moderate/severe pain, over 80% of 
patients in the first period and over 85% in the second 
period rated the quality of analgesia as very good or good, 
irrespective of the group. This result shows that 100 μg of 
morphine do not promote more satisfying analgesia than 50 
μg and demonstrates the difficulty of relating pain intensity 
with level of satisfaction.1
In 70% of patients in Group 50, pain was the event that 
bothered the most over 24 hours. In Group 100, pain also 
was the most bothering event; however, it occurred in 38% of 
patients, while 32% reported pruritus as the main factor of 
discomfort in the same period. Considering that the quality 
of analgesia was similar between groups, one possible 
explanation for this result is a difference in the intensity of 
side effects. A more intense pruritus in Group 100 justifies 
the number of patients who elected it as the main cause 
of discomfort in the 24 hours after cesarean. This result is 
consistent with those of Palmer et al.6 and Girgin et al.13 
who reported pruritus intensity varying proportionally with 
the intrathecal dose of morphine used.
Our results suggest that 50 μg of intrathecal morphine 
are closer to the optimal dose for analgesia after 
cesarean section than 100 μg, as it provide the same 
quality of analgesia with lower incidence of side effects. 
Pruritus was statistically more frequent in Group 100 and 
considered the main factor of discomfort over 24 hours 
in 32% of patients in this group. Due to its incidence and 
importance, this side effect should be investigated and 
treated routinely. Patients undergoing caesarean section 
should have access to additional systemic analgesics to 
improve the quality of analgesia because, regardless of 
morphine dosage, a large number of patients experience 
moderate/severe pain.
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